norfloxacin has been researched along with Urinary Tract Diseases in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newsom, SW | 1 |
| Westenfelder, M | 1 |
| Vahlensieck, W | 1 |
| Reinhartz, U | 1 |
2 other studies available for norfloxacin and Urinary Tract Diseases
| Article | Year |
|---|---|
The clinical use of quinolones.
Topics: Ciprofloxacin; Escherichia coli; Feces; Female; Genital Diseases, Female; Genital Diseases, Male; Hu | 1986 |
Patient compliance and efficacy of low-dose, long-term prophylaxis in patients with recurrent urinary tract infection.
Topics: Adult; Anti-Infective Agents; Child; Follow-Up Studies; Humans; Norfloxacin; Patient Compliance; Pyr | 1987 |